Expertise in
27
conditions

Dr. Usha S. Perepu

Hematology
Capsule Pharmacy
8435 Wurzbach Rd, 
San Antonio, TX 
Accepting New Patients
Expertise in
27
conditions
Capsule Pharmacy
8435 Wurzbach Rd, 
San Antonio, TX 

Overview

Usha Perepu is a Hematologist practicing medicine in San Antonio, Texas.

Dr. Perepu is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Von Willebrand Disease (VWD), Myeloproliferative Neoplasms (MPN), Heyde Syndrome, Bone Marrow Aspiration, and Splenectomy.

She is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 4 clinical trials. Dr. Perepu is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in IA

Hospital Affiliations

University Health System
UT Health San Antonio Multispecialty & Research Ho

Languages Spoken

English
Hindi
Telugu

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community First Health Plans
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Sanford Health
  • HMO
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Capsule Pharmacy
8435 Wurzbach Rd, San Antonio, TX 78229
Other Locations
University of Texas Health Science Center at San Antonio
7979 Wurzbach Rd, San Antonio, TX 78229

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
Enrollment Status: Completed
Publish Date: March 17, 2026
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 2
A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination With BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients With Molecular Evidence of Disease
A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination With BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients With Molecular Evidence of Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2025
Intervention Type: Drug, Other
Study Drugs: Bosutinib, Dasatinib, Nilotinib, Nilotinib Hydrochloride Monohydrate, Ruxolitinib, Ruxolitinib Phosphate
Study Phase: Phase 2
A Phase III, Randomized, Controlled, Double-Blind Study Evaluating the Safety of Two Doses of Apixaban for Secondary Prevention of Cancer Related Venous Thrombosis in Subjects Who Have Completed at Least Six Months of Anticoagulation Therapy
A Phase III, Randomized, Controlled, Double-Blind Study Evaluating the Safety of Two Doses of Apixaban for Secondary Prevention of Cancer Related Venous Thrombosis in Subjects Who Have Completed at Least Six Months of Anticoagulation Therapy
Enrollment Status: Completed
Publish Date: May 18, 2025
Intervention Type: Drug
Study Drug: Apixaban
Study Phase: Phase 3
A Phase III, Randomized, Open Label Study Evaluating the Safety of Apixaban in Subjects With Cancer Related Venous Thromboembolism
A Phase III, Randomized, Open Label Study Evaluating the Safety of Apixaban in Subjects With Cancer Related Venous Thromboembolism
Enrollment Status: Completed
Publish Date: August 04, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
View 3 Less Clinical Trials

15 Total Publications

Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis.
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis.
Journal: Annals of internal medicine
Published: December 23, 2024
Similar Doctors
Expertise in
8
conditions
Expertise in
8
conditions
Referral may be required

University Of Texas Health Science Center At San Antonio

7979 Wurzbach Rd, 
San Antonio, TX 
 (0.5 miles away)
210-450-1406
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robyn Scherber is a Hematologist practicing medicine in San Antonio, Texas. Dr. Scherber is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, and Bone Marrow Transplant. Dr. Scherber is currently accepting new patients.

Expertise in
16
conditions
Dr. Ildefonso I. Rivera
Hematology | Oncology
Expertise in
16
conditions
Dr. Ildefonso I. Rivera
Hematology | Oncology
Referral may be required

Office

2829 Babcock Rd Ste 300, 
San Antonio, TX 
 (1.3 miles away)
210-580-9500
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ildefonso Rivera is a Hematologist and an Oncologist practicing medicine in San Antonio, Texas. Dr. Rivera is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Gastric Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Follicular Lymphoma. Dr. Rivera is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Texas Oncology Pharmacy San Antonio

5206 Research Dr, 
San Antonio, TX 
 (2.0 miles away)
210-595-5300
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Roger Lyons is a Hematologist practicing medicine in San Antonio, Texas. Dr. Lyons is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Idiopathic Neutropenia, Agranulocytosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Splenectomy. Dr. Lyons is currently accepting new patients.

Frequently Asked Questions about Dr. Usha S. Perepu

How do I make an appointment with Dr. Usha S. Perepu?

You can book an appointment with Dr. Usha S. Perepu by calling their office at 210-450-7334. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Usha S. Perepu a top-rated expert for Von Willebrand Disease (VWD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Usha S. Perepu is classified as an Distinguished expert for Von Willebrand Disease (VWD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Usha S. Perepu specialize in?

While Dr. Usha S. Perepu is a Hematology, they have specific expertise in Von Willebrand Disease (VWD), Myeloproliferative Neoplasms (MPN), and Heyde Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Usha S. Perepu participate in research or clinical trials?

Yes. Dr. Usha S. Perepu has published 15 articles and abstracts on conditions like Von Willebrand Disease (VWD). You can view a list of Dr. Usha S. Perepu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Usha S. Perepu accept my insurance?

Dr. Usha S. Perepu accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 210-450-7334 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Perepu's expertise for a condition
ConditionClose
    View All 22 Advanced Conditions
    View All 49 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile